Email not displaying correctly? See online newsletter
HIV in Europe Newsletter
Issue No. 5  - October 2010

News from the HIV in Europe initiative and links to national testing guidelines and initiatives.

The Indicator Diseases Across Europe Study at the 10th International Congress on Drug Therapy in HIV Infection in Glasgow, 7-11 November 2010

Oral presentation
Title: A pilot study to determine the prevalence of HIV in persons presenting for care with selected conditions: preliminary results from the HIV in Europe study
08 November 2010, IAS Session & Trust Report Session, 14:20 - 16:30
Presenter: Anders Sönnerborg, Karolinska University Hospital, Sweden

Indicator Diseases Study group meeting
10 November, 7:30 - 8:30, Ness Room, Conference Venue

Please confirm your participation to

Links to National Initiatives and Guidelines
After the 2009 Stockholm Conference and in order to keep up the momentum around earlier diagnosis and care of HIV in Europe, the HIV in Europe Steering Committee established a group of 'national rapporteurs', with the aim of updating each other and others on developments on national level in relation to national testing guidelines and/or other political and local initiatives on testing and earlier care. 

Please find recent country reports at the HIV in Europe website. Thanks to all national rapporteurs! Additional reports can be send to the secretariat

Recent HIV in Europe Publications and

1. Late presentation of HIV infection: A consensus definition, European late presenter working group, HIV Medicine 2010,  Published Online: 17 Jun 2010

2. Overcoming obstacles to late presentation for HIV in Europe, Jeffrey V. Lazarus, Ralf Jürgens, Matthew Weait, Andrew Phillips, Julian Hows, José Gatell, Ton Coenen, Anders Sönnerborg, Dorthe Raben, Jens D. Lundgren, HIV Medicine, Published Online: 29 August 2010

3. Methods and data requirements for the estimation of the number of people with HIV, Working group on Estimation of HIV Prevalence in Europe, AIDS, in press

4. International AIDS Conference, Vienna, July 2010
The oral presentation from the regional Session on Europe and Central Asia and poster presentations are available at:


Financial support of the initiative has been provided by Gilead Sciences, Merck, Tibotec, Pfizer, Schering-Plough, Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, ViiV Healthcare and the Swedish Research Council.